CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Rohan Takalkar

Security Intelligence Services posts decline in bottomline

Security Intelligence Services reported subdued bottomline for the quarter and higher revenues and operational profits 

The total revenue for the quarter rose by 28.6 per cent in Q4FY18 to Rs.1592 crore vs Rs.1238 crore in Q4FY17. This was largely aided by 31 per cent increase in revenue by Australian services and 24 per cent YoY increase in Indian services. 

The operating profit for the quarter rose by 33.5 per cent YoY to Rs.87 crore in Q4FY18 vs Rs.65 crore in Q4FY17. The EBITDA margin for the quarter rose by 20 bps to 5.5 per cent as against 5.3 per cent in the corresponding quarter previous year. 

The company posted decline in net profit to Rs 36 crore in Q4FY18 as compared with Rs.55 crore in the corresponding quarter previous year. The associate company's net loss was Rs 5 crore in Q4FY18 vs Rs.1 crore profit during the same period previous year. 

On a full year basis, the net revenue grew by 33.8 per cent YoY, while EBITDA for the quarter rose by 58 per cent YoY, and the bottomline grew by 48.6 per cent 

Previous Article Zydus Cadila receives final USFDA approval for Carbidopa Tablets
Next Article Fairchem posts stellar Q4FY18 results
Print
806 Rate this article:
5.0
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR